Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02688166 · ClinicalTrials.gov registry record
Cardiac MRI Biomarker Testing (GCC 1618)
A clinical trial, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- 6
- Enrollment target
NCT02688166: Clinical Trial study, sponsored by University of Maryland, Baltimore.
NCT02688166 is a clinical trial that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02688166 was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This research study can help understand how cardiac changes may occur with radiation therapy to the heart based off measurements obtained through biomarkers and cardiac imaging. Researchers plan to perform cardiac imaging and biomarkers for any cardiac injury. Cardiac magnetic resonance imaging (CMR) provides the ability to quantitatively measure cardiac function and injury. The cardiac biomarkers that will be tested are effective in the diagnosis, risk-stratification, and monitoring of heart failure.
Interventions
- OTHER Complete Cardiac Magnetic Resonance Imaging (MRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2022-09-09 |
Why NCT02688166 stopped before completion
NCT02688166 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Complete Cardiac Magnetic Resonance Imaging (MRI) is the first listed.
NCT02688166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02688166 about?
NCT02688166 is a clinical study titled "Cardiac MRI Biomarker Testing (GCC 1618)". This research study can help understand how cardiac changes may occur with radiation therapy to the heart based off measurements obtained through biomarkers and cardiac imaging. Researchers plan to perform cardiac imaging and biomarkers for any cardiac injury. Cardiac magnetic resonance imaging (CM...
What is the current status of trial NCT02688166?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2018-02-01. Estimated completion is 2022-09-09.
What interventions are being tested in trial NCT02688166?
The interventions under investigation include: Complete Cardiac Magnetic Resonance Imaging (MRI) (OTHER).
Who is sponsoring clinical trial NCT02688166?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI